Piper Sandler Maintains Overweight on Organon, Raises Price Target to $24
Organon & Co. Common Stock -0.57%
Organon & Co. Common Stock OGN | 17.35 | -0.57% |
Piper Sandler analyst David Amsellem maintains Organon (NYSE:
OGN) with a Overweight and raises the price target from $22 to $24.